{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:45:02Z","timestamp":1790689502098,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002669","name":"Elekta AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijrobp.2024.01.012","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T08:42:55Z","timestamp":1708504975000},"page":"516-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disease Control and Late Toxicity in Adaptive Dose Painting by Numbers Versus Nonadaptive Radiation Therapy for Head and Neck Cancer: A Randomized Controlled Phase 2 Trial"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-481X","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"De Bruycker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"De Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Daisne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Vercauteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"De Gersem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"Olteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Berwouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Deheneffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9deric","family":"Duprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.01.012_bib0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site","volume":"100","author":"Blanchard","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0003","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2152\/jmi.60.46","article-title":"Changes of tumor and normal structures of the neck during radiation therapy for head and neck cancer requires adaptive strategy","volume":"60","author":"Bando","year":"2013","journal-title":"J Med Invest"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2006.12.070","article-title":"Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer","volume":"68","author":"Madani","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0006","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2967\/jnumed.109.062638","article-title":"Dose painting in radiotherapy for head and neck squamous cell carcinoma: Value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI","volume":"50","author":"Dirix","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2008.05.021","article-title":"Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers","volume":"89","author":"Soto","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0008","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","article-title":"Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake","volume":"111","author":"Due","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196310","article-title":"Impact of different biologically-adapted radiotherapy strategies on tumor control evaluated with a tumor response model","volume":"13","author":"Gago-Arias","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.radonc.2010.03.007","article-title":"Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation","volume":"95","author":"Castadot","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1470-2045(05)01737-7","article-title":"Theragnostic imaging for radiation oncology: Dose-painting by numbers","volume":"6","author":"Bentzen","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0012","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2010.03.028","article-title":"Adaptive dose painting by numbers for head-and-neck cancer","volume":"80","author":"Duprez","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.radonc.2011.06.020","article-title":"Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer","volume":"101","author":"Madani","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0014","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2013.04.002","article-title":"Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: Initial results of the phase I clinical trial","volume":"107","author":"Berwouts","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.radonc.2006.03.003","article-title":"[18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer","volume":"79","author":"Vanderstraeten","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0016","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/0284186X.2017.1364867","article-title":"Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer","volume":"57","author":"Olteanu","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0017","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2016.08.009","article-title":"Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; A randomized clinical trial. Effect on late toxicity and tumor control","volume":"122","author":"Nevens","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0018","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2020.09.063","article-title":"Prospective phase 2 study of radiation therapy dose and volume de-escalation for elective neck treatment of oropharyngeal and laryngeal cancer","volume":"109","author":"Sher","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0019","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.radonc.2013.03.002","article-title":"A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach","volume":"106","author":"Leclerc","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0020","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/hed.24892","article-title":"Long-term outcome of (18) F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study","volume":"39","author":"Berwouts","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0021","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2020.01.005","article-title":"Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome","volume":"143","author":"Deschuymer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11136-020-02628-w","article-title":"Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma: Results on the quality of life","volume":"30","author":"Deschuymer","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0023","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.radonc.2020.10.039","article-title":"18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO)","volume":"155","author":"Michaelidou","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0024","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ijrobp.2007.03.013","article-title":"Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers","volume":"69","author":"Lee","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0025","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/archoto.2009.174","article-title":"Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer","volume":"135","author":"Givens","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0026","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.radonc.2013.12.007","article-title":"Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer","volume":"110","author":"Vlacich","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0027","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijrobp.2008.04.048","article-title":"Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer","volume":"73","author":"Caudell","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0028","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2019.02.021","article-title":"The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis","volume":"135","author":"Smith","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.01.012_bib0029","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1470-2045(09)70023-3","article-title":"Surrogate endpoints for overall survival in locally advanced head and neck cancer: Meta-analyses of individual patient data","volume":"10","author":"Michiels","year":"2009","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624000257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624000257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T10:21:47Z","timestamp":1738146107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0360301624000257"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.01.012","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease Control and Late Toxicity in Adaptive Dose Painting by Numbers Versus Nonadaptive Radiation Therapy for Head and Neck Cancer: A Randomized Controlled Phase 2 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}